Fig. 5From: Pilot study of ziv-aflibercept in myopic choroidal neovascularisation patientsa OCT after the first injection of ziv-aflibercept with reduced CMT to 226 um. b OCT after the second injection of ziv-aflibercept with reduced CMT to 213um. c OCT after the third injection of ziv-aflibercept, the CMT declined to 184 umBack to article page